Artificial Intelligence (AI) is transforming industries, and drug development is no exception. The regulatory lifecycle, a critical part of therapeutic drug development, offers numerous opportunities for AI to streamline processes, reduce errors, and accelerate time to market.How do you effectively incorporate AI into this complex lifecycle? It requires a thoughtful approach and a clear framework to ensure success, which we present here as five key elements.
Commentary
The regulatory lifecycle + AI
Related resources
Release note
Weave Platform April 2026 release notes
The April 2026 Weave Platform release introduces NDA submission support and updates to HAQ Manager that help teams streamline submission…
Read more
Release note
Weave Platform March 2026 release notes
The March 2026 Weave Platform release introduces updates to Context Management and HAQ Manager that help teams better control AI…
Read more
Release note
Weave Platform February 2026 release notes
The February 2026 Weave Platform release introduces new capabilities that help teams review documents faster and simplify publishing workflows across…
Read more
Customer stories
Scientific Rigor at Speed: Trace Biosciences’ First IND Experience
Trace Biosciences recently prepared and submitted its first Investigational New Drug (IND) application while advancing a nerve-targeted molecular imaging agent…
Read more